Summer 2015 - Vaccines

Novo Nordisk and Janssen Sign an Agreement

Novo Nordisk has signed an agreement with Janssen Biotech Inc. for Janssen to acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases.

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.